Grifols SA files 6-K

Grifols, S.A. announced it is evaluating a potential Initial Public Offering (IPO) in the United States of a portion of the shares of its subsidiary and parent of its U.S. Biopharma business. This potential transaction is part of the company's self-sufficiency programs for its Biopharma businesses.